European Cooperative Acute Stroke Study "ECASS-I"
Completed
Phase 3 ResultsReferences
Source for Trial Information
- JAMA 1995 Oct 4;274(13):1017-25.
Recruitment
- Minimum Age: 18
- Maximum Age: 80
- Study Size: 620
- Number of Centers: 75
- Max Time from Onset: 6 Hours
- Follow Up: 90 Days
Principal Investigator
-
Werner Hacke, M.D.
Department of Neurology, University of Heidelberg, Heidelberg, Germany